IL10 and metabolic syndrome: IL-10 substitution might pose a viable treatment strategy for atrial dysfunction (arrhythmias, contractile dysfunction) in the setting of metabolic syndrome-related HFpEF and its efficacy should be further evaluated in preclinical trials.